Time to treatment Disease remission Seizure severity Sub-Saharan Africa a b s t r a c t Objectives: To investigate the relationship between time to antiepileptic drug (AED) treatment (TTT) and seizure outcome in a high treatment gap sub-Sahara African setting. Methods: Clinical and demographic characteristics of 72 adults with epilepsy aged 18-75 years were obtained. We estimated TTT as the difference between the duration of epilepsy and the duration of treatment. Indices of clinical outcome including seizure severity and 6-month disease remission were documented. The effects of TTT and other clinical and demographic characteristics on clinical outcomes were tested using bivariate and logistic regression analyses.Results: Forty (55.6%) of the participants initiated treatment within 5 years of seizure onset (TTT ≤ 5 years) while 32 (44.4%) initiated treatment after 5 years (TTT > 5 years). There was moderate to strong correlation between TTT and age of onset ( p = .009), age at treatment initiation ( p = .026), duration of epilepsy ( p = .000), and seizure severity ( p = .020). The TTT > 5 years group had an earlier mean age of onset ( p = .015) and higher seizure severity score ( p = .001) and were less likely to be in 6-month disease remission ( p = .014). Time to treatment ≤5 years was the only independent predictor of lesser seizure severity (OR = 0.163, 95% CI = 0.041-0.649) and better 6-month remission (OR = 0.154, 95% CI = 0.031-0.770) after adjusting for age of onset, duration of epilepsy, and number of AEDs.Conclusion: Delayed treatment initiation is common in our sample and independently associated with poor seizure outcome.